Jazz Pharmaceuticals plc JAZZ
229.74 USD +15.30 (+7.13%)
At closeNov 3, 2026, 4:03 PM EST
229.74 0.00 0.00%
After hours · Nov 3, 4:03 PM ET
218.53 Day range 234.78
128.80 52-week range 266.38
- YTD
- +35.14%
- 1 year
- +66.02%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 295.77 +28.7% upside
Now 229.74
- Target (low)
- 225.00
- Target (mean)
- 295.77
- Target (high)
- 337.00
Ratings (0m) 22 20 buy · 2 hold · 0 sell
- Strong buy7
- Buy13
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 22
- 1 month ago 22
- 2 months ago 22
- 3 months ago 20
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -2.38 | -4.72 – 5.81 | 8.13 | -129.2% | 1.28B | +6.9% | 13 |
| Next quarter | 6.64 | 5.30 – 8.78 | 6.64 | -0.0% | 1.13B | +6.0% | 15 |
| Current year | 15.00 | 13.98 – 15.97 | 8.38 | +79.0% | 4.80B | +12.6% | 14 |
| Next year | 26.00 | 13.70 – 32.14 | 15.00 | +73.4% | 5.06B | +5.3% | 16 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 3, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 3, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Nov 3, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 3, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 28, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 21, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 8, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 7, 2026 | Truist Securities | Maintained | Buy | Buy |
| Sep 30, 2026 | Citigroup | Initiated | — | Buy |
| Sep 11, 2026 | UBS | Maintained | Buy | Buy |
| Sep 10, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 26, 2026 | Deutsche Bank | Maintained | Buy | Buy |
| Aug 26, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 26, 2026 | Truist Securities | Maintained | Buy | Buy |
| Aug 26, 2026 | Needham | Maintained | Buy | Buy |
| Aug 11, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 4, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 4, 2026 | Truist Securities | Maintained | Buy | Buy |
| Aug 4, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 4, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Aug 4, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 4, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 4, 2026 | Needham | Maintained | Buy | Buy |
| Aug 4, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 4, 2026 | Baird | Maintained | Outperform | Outperform |
| Jul 20, 2026 | Needham | Maintained | Buy | Buy |
| Jul 17, 2026 | Canaccord Genuity | Initiated | — | Buy |
| Jul 14, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 14, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 9, 2026 | Deutsche Bank | Maintained | Buy | Buy |
